European Medicines Agency warns against counterfeit Herceptin

European Medicines Agency recommends restriction of use of Protelos/Osseor

Prescription of CHCs and importance of individual risk factors.

Re-evaluation with regard to higher body weight or BMI

The preparation Eldisin 5 mg dry ampoules (active ingredient: vindesine sulfate) has been approved in Austria since March 29, 1984. Vindesine is a cytostatic drug from the group of vinca alkaloids and has proven effective primarily in combination…

Policy 0070 on publication and access to clinical-trial data

New management of AGES Medical Market Surveillance

The European Union has introduced a new labeling for medicinal products that are subject to particularly close monitoring. These medicines are identified in the package leaflet by a black triangle ▼ standing on its tip with the words: "This medicinal…

Many medicinal products, when stored appropriately, remain in compliance with their specifications for much longer than can be expected on the basis of their expiration date. If you want to use such stocks of medicinal products safely and…

Metoclopramide-containing medicinal products are approved in a number of Member States in various indications, including nausea and vomiting (for example, after chemotherapy or radiotherapy, surgery, or for migraine) and gastrointestinal motility…